When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
SYRS - Syros Pharmaceuticals Platform Undervalued After Dip
Syros Pharmaceuticals Inc.
Syros Pharmaceuticals (SYRS) has not been doing well in the market since it peaked at $24.31 per share on July 24, 2017. Excitement over some early preclinical- and clinical-stage results has died down, and two cash raises have pointed out the dilution downside potential of poorly capitalized small biotech stocks. In particular, the $70 million cash raise announced on April 5, 2019, caused a 33% drop to close out the day at $7.48. Still, that was above the 52-week low of $5.17.
I believe Syros is priced low enough to be of interest